Comparison of the pharmacodynamic and pharmacokinetic profiles of single and multiple doses of a commercial slow-release metoprolol formulation with a new Oros delivery system.-Reference-Cited by-同舟云学术

Comparison of the pharmacodynamic and pharmacokinetic profiles of single and multiple doses of a commercial slow-release metoprolol formulation with a new Oros delivery system.

Published:1982-03 Issue:3 Volume:13 Page:393-398
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:British Journal of Clinical Pharmacology

Author:

Kendall MJ,Jack DB,Woods KL,Laugher SJ,Quarterman CP,John VA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1982.tb01391.x/fullpdf

Reference18 articles.

1. β-adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers;AELLIG;Br. J. clin. Pharmac.,1976

2. An eighteen months' study of the clinical response to metoprolol, a selective beta receptor blocking agent, in patients with angina pectoris;COMERFORD;Postgrad, med. J.,1976

3. Simplified method for the determination of oxprenolol and other β-receptor blocking agents in biological fluids by gas-liquid chromatography;DEGEN;J. Chromatog.,1976

4. Osmotically actuated dosage forms for rate-controlled drug delivery;ECKENHOFF;Pharm. Technol.,1981

5. Disposition of propranolol. V Drug accumulation and steady state concentration during chronic oral administration in man;EVANS;Clin. Pharmac. Ther.,1973

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine;CNS Drugs;2017-04-12

2. Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release;Chemical Reviews;2016-02-08

3. The relevance of CYP2D6 genetic polymorphism on chronic metoprolol therapy in cardiovascular patients;Journal of Clinical Pharmacy and Therapeutics;2006-02

4. Osmotic Pumps in Drug Delivery;Critical Reviews in Therapeutic Drug Carrier Systems;2004

5. Osmotically Controlled Oral Drug Delivery*;Drug Development and Industrial Pharmacy;2000-01